风险分析临床决策支持减少儿童心脏术后血管活性药物输注时长:多中心前后对照临床试验
该多中心前后对照研究在3家三级儿童医院心脏ICU纳入接受体外循环心脏手术后使用血管活性药物≥6小时的婴儿(胎龄>36周且体重>2kg),干预组343例、对照组432例。干预为临床医生承诺在撤药计划中参考基于6小时滚动IDo2平均值的临床决策支持系统数据。风险校正负二项回归显示干预组血管活性药物输注时长缩短29%(95%CI 14-42%,p<0.01),但ICU住院时长、心脏骤停率和撤药失败率无显著变化趋势。
要点
- 干预组343例、对照组432例,风险校正负二项回归显示干预组血管活性药物输注时长缩短29%(95%CI 14-42%,p<0.01)。
- 干预组STAT 4患者比例更高(81 vs 62,p<0.01),STAT 1患者比例更低(43 vs 108,p<0.01)。
- ICU住院时长、心脏骤停发生率、血管活性药物撤药失败率均无显著变化趋势。
- 干预方式为临床医生承诺在术后撤药计划中参考基于6小时滚动IDo2平均值的临床决策支持系统数据。
- 研究纳入胎龄>36周且体重>2kg、体外循环心脏术后使用血管活性药物≥6小时的婴儿。
适用人群与场景
- 3家三级学术儿童医院心脏ICU中,胎龄>36周且体重>2kg、接受体外循环心脏手术后使用血管活性药物(IVAI)≥6小时的婴儿。
处置流程与药物剂量
- 临床医生承诺在术后撤药计划中参考基于6小时滚动氧输送不足指数(IDo2)平均值的临床决策支持系统(CDSS)数据;系统中记录纳入这些数据的决策即 prompts 患者进入干预组。
研究设计与关键结果
- 多中心前后对照研究,2020年6月1日至2022年12月31日,干预组343例、对照组432例;主要终点为血管活性药物输注时长。
- 风险校正负二项回归模型显示干预组血管活性药物输注时长缩短29%(95%CI 14-42%,p<0.01)。
- 干预组STAT 4患者比例更高(81 vs 62,p<0.01),STAT 1患者比例更低(43 vs 108,p<0.01)。
- ICU住院时长、心脏骤停发生率、血管活性药物撤药失败率均无显著变化趋势。
证据类型、等级与局限
- 多中心前后对照临床试验;局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,基于IDo2的临床决策支持系统可显著缩短儿童心脏术后血管活性药物输注时长,未观察到ICU住院时长、心脏骤停率或撤药失败率的变化。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Our primary objective was to quantify the effect of a clinical decision support system (CDSS) informed by inadequate delivery of oxygen index (ID o2 ), an algorithm that estimates the probability of inadequate oxygen delivery on inotropes and vasoactive infusions (IVAI) postoperatively.
DESIGN: Multicenter before-and-after study conducted between June 01, 2020, and December 31, 2022.
SETTING: Three pediatric cardiac ICUs (CICUs) at tertiary academic children's hospitals.
PATIENTS: Infants older than 36 weeks estimated gestational age and 2 kg following cardiac surgery with cardiopulmonary bypass, treated with IVAI greater than or equal to 6 hours.
INTERVENTIONS: Clinicians committed to consider data from a CDSS informed by 6 hours rolling ID o2 average in their plan to wean IVAI postoperatively. Within the system, documentation of decisions incorporating these data prompted patient inclusion in the intervention arm.
MEASUREMENTS AND MAIN RESULTS: The primary outcome measure was IVAI duration. Secondary outcomes were CICU length of stay (LOS), rate of cardiac arrest (CA), and rate of IVAI weaning failure. Negative binomial and logistic regression models were used to assess differences between intervention and control groups. Age, sex, Society of Thoracic Surgeons-European association for Cardio-Thoracic Surgery (STAT) category, site, admit time, single-ventricle diagnosis, Vasoactive-Inotropic Score, and trial group were tested as input covariates. Three hundred forty-three and 432 patients were enrolled in the intervention and control groups, respectively. The intervention group included a higher proportion of STAT 4 patients and a lower proportion of STAT 1 patients (81 vs. 62; p < 0.01 and 43 vs. 108; p < 0.01, respectively). A risk-adjusted negative binomial regression model showed 29% shorter vasoactive infusion duration in the intervention group (95% CI, 14-42%; p < 0.01). There were no significant trends observed in CICU LOS, or occurrence rate of CA or weaning failure.
CONCLUSIONS: A CDSS informed by ID o2 significantly decreased vasoactive infusions duration. There was no discernible change in ICU LOS, CA rate, or weaning failure rate.
参考来源
- Gazit AZ, Futterman C, Baronov D, et al. Risk Analytics Clinical Decision Support Decreases Duration of Vasoactive Infusions Following Pediatric Cardiac Surgery: A Multicenter Before and After Clinical Trial. Crit Care Med. 2025. PMID: 40298483. doi:10.1097/CCM.0000000000006682
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。